Rarascro
Business Services · Brazil · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2033 suite 81 Avenida Ibirapuera, Sao Pa...Website
www.rarascro.comRevenue
<$5 MillionIndustry
About Rarascro
Rarascro Org Chart
Is Rarascro your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Rarascro, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Rarascro launches new products
Check out if Rarascro is spiking on competitors!
Earning: See what the market has to say on Rarascro recently announced quarterly report
Check if Rarascro has recently received funding, and reach out quickly before it becomes old news!
Click to see if Rarascro had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Rarascro has new funding data
Congratulate Masked Content for being promoted to Masked Content at Rarascro
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Rarascro
Find 2 more new buyers
Company Profile Activity
Activity Insights
Rarascro is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Rarascro is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Rarascro.
Rarascro Tech Stack
A closer look at the technologies used by Rarascro
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rarascro
Raras CRO specializes in facilitating the journey of healthcare companies in Latin America by providing innovative solutions and comprehensive support throughout the product lifecycle, from pre-clinical stages to commercialization. They offer a launch platform for developing pharmaceutical and medical device assets, ensuring rapid investor value ge... Read More